• XPO1 Inhibition by Eltanexor Modulates Wnt/β-catenin in CRC

  2026-05-07

  This study demonstrates that Eltanexor (KPT-8602), a second-generation XPO1 inhibitor, effectively reduces colorectal cancer (CRC) tumorigenesis by modulating the Wnt/β-catenin signaling pathway and decreasing COX-2 expression. The findings highlight the chemopreventive potential of XPO1 inhibition in CRC and provide mechanistic insights for researchers developing targeted cancer therapeutics.

• CUDC-907: Technical Guidance for Dual PI3K and HDAC Inhibiti

  2026-05-06

  CUDC-907 is a dual PI3K and HDAC inhibitor formulated for in vitro research workflows targeting cancer cell signaling, especially where simultaneous inhibition of PI3K/AKT and histone deacetylase activity is required. It should be used strictly in controlled cell-based assay systems and is not appropriate for diagnostic or clinical applications.

• Lamotrigine in Cardiac and CNS Research: Novel Mechanistic H

  2026-05-06

  Explore Lamotrigine’s unique role as a sodium channel blocker and 5-HT inhibitor in both cardiac and CNS research. This article offers advanced insights into mechanistic selectivity, assay optimization, and cross-domain implications, setting a new benchmark for scientific rigor.

• Strategic Advances in Apoptosis and Akt Inhibition with Peri

  2026-05-05

  This article explores the mechanistic and translational potential of Perifosine (KRX-0401), a synthetic alkylphospholipid Akt inhibitor, in apoptosis and Akt/mTOR pathway research. Integrating recent advances in cancer and neuroprotection, the piece provides strategic guidance for translational researchers and positions APExBIO’s Perifosine as a critical tool for reproducibility and workflow optimization.

• MTT: Precision In Vitro Cell Proliferation and Viability Ass

  2026-05-05

  MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) stands as a gold-standard reagent for in vitro cell proliferation and metabolic activity quantification. This article details advanced workflows, troubleshooting, and protocol enhancements, with insights from the latest nanoparticle-based breast cancer stem cell research.

• KR-12 Human Antimicrobial Peptide: Assay Workflow & Troubles

  2026-05-04

  KR-12, the minimal active fragment of LL-37, stands out for its precise antimicrobial targeting, copper-binding characteristics, and low cytotoxicity. This article details advanced experimental workflows, troubleshooting insights, and protocol enhancements, empowering researchers to maximize the translational potential of KR-12 (human) TFA.

• Scenario-Driven Solutions with Methylprednisolone Sodium Suc

  2026-05-04

  This evidence-based article addresses real laboratory challenges in cell viability and inflammation research, illustrating how Methylprednisolone Sodium Succinate (SKU B4953) supports reproducible, high-sensitivity workflows. Practical Q&A scenarios guide researchers through protocol optimization, data interpretation, and vendor selection for robust results.

• γH2AX DNA Damage Detection: Bridging Mechanism to Applicatio

  2026-05-03

  Explore how precise γH2AX detection redefines translational research in DNA damage, radiotherapy response, and immune modulation—integrating mechanistic insights, leading-edge experimental evidence, and strategic guidance for researchers aiming to accelerate discoveries from bench to bedside.

• Dual Metabolic Reprogramming Boosts Ferroptosis in TNBC Ther

  2026-05-02

  This study introduces a metal-polyphenol nanoplatform that co-targets iron and lipid metabolism, advancing ferroptosis-based therapy for triple-negative breast cancer (TNBC). By unveiling compensatory resistance mechanisms and proposing dual inhibition of DHODH and DGAT1, the research provides a new framework for overcoming therapeutic resistance in aggressive cancers.

• Bismuth Subsalicylate: Strategic Insights for GI Translation

  2026-05-01

  Discover how Bismuth Subsalicylate (1,3,2λ2-benzodioxabismin-4-one) is reshaping gastrointestinal disorder research through advanced mechanistic understanding and practical translational strategies. This article offers a multidimensional perspective on inflammation pathway modulation, protocol optimization, and competitive positioning, grounded in evidence and actionable recommendations for researchers.

• Quercetin Modulates Glucose and Lipid Metabolism in GDM via

  2026-05-01

  This study identifies quercetin as a regulator of glucose and lipid metabolism in gestational diabetes mellitus (GDM) through modulation of the PCSK9/LDLR axis and activation of the PI3K/AKT/GSK3β pathway. The findings highlight both molecular and functional improvements in glucose uptake and lipid profiles, suggesting translational potential for metabolic disease research.

• Ceapin-A7: Selective ER Stress Blocker for Precision Pathway

  2026-04-30

  Ceapin-A7 stands out as a selective ER stress blocker, enabling researchers to modulate the ATF6α pathway with unmatched specificity. Its robust performance in unfolded protein response studies, along with clear protocol guidance, supports advanced disease modeling and mechanism dissection.

• L-NAME Hydrochloride in Translational CI-AKI and Apoptosis R

  2026-04-30

  Explore the advanced applications of L-NAME Hydrochloride (NG-nitro-L-arginine methyl ester) in apoptosis and inflammation signaling modulation, with a unique focus on acute kidney injury models and translational assay design. Discover how APExBIO’s reagent supports cutting-edge vascular and renal research.

• Anti-Fibrotic Effects of 1-Phenyl-2-Pentanol on Hepatic Stel

  2026-04-29

  This study identifies 1-phenyl-2-pentanol, a compound from Moringa oleifera, as a potent inhibitor of hepatic stellate cell activation and fibrogenic signaling in vitro. By elucidating its mechanism—targeting both TGF-β1 and Wnt/β-catenin pathways—the research offers new directions for anti-fibrotic drug development.

• Hexetidine (NSC-17764): Reliable Biofilm & Oral Antimicrobia

  2026-04-29

  This article provides laboratory researchers with scenario-driven guidance on leveraging Hexetidine (NSC-17764), SKU BA1327, as a robust, reproducible solution for biofilm inhibition, oral infection models, and cell-based assays. Integrating literature-backed data, real-world troubleshooting, and vendor selection advice, the piece empowers scientific decision-making and highlights APExBIO’s Hexetidine for sensitive, evidence-driven workflows.

14570 records 1/972 page Next 12345 下5页 Last page